Two More NovaSeq™ X Plus: CeGaT Expands Sequencing Power
With four NovaSeq™ X Plus systems now in operation, we provide the high-throughput sequencing power required to deliver…
CeGaT GmbH
CeGaT Introduces CancerMRD: Personalized and Non-Invasive Tumor Monitoring
CeGaT GmbH, a global provider of genetic diagnostics and sequencing services, proudly announces the launch of CancerMRD,…
CeGaT Enhances ExomeXtra® for Deeper Genetic Insights
CeGaT, a global provider of genetic diagnostics and sequencing services, announces significant advancements in exome dia…
CeGaT Expands Genetic Testing Services to U.S. and Canada, Partnering with Major Insurers
CeGaT, a global provider of genetic testing and sequencing services, announces the expansion of its world-class genetic…
CeGaT Has Multiple Reasons to Celebrate
CeGaT, a global provider of genetic diagnostics and sequencing services based in Tübingen, Germany, is celebrating sever…
CeGaT hat mehrfach Grund zu feiern
CeGaT, ein weltweiter Anbieter von genetischer Diagnostik und Sequenzierdienstleistungen mit Sitz in Tübingen, feiert d…
CeGaT Revolutionizes Exome Diagnostics with Genome-wide CNV Analysis
CeGaT, a global provider of genetic diagnostics and sequencing services, presents an innovation in exome diagnostics: Wi…
CeGaT Is One of the First Companies Worldwide to Receive the Most Powerful Sequencing Platform NovaSeq™ X Plus
CeGaT, a global provider of sequencing services for research, clinical studies, and human genetic diagnostics, is now us…
CeGaT erhält als eines der ersten Unternehmen weltweit die leistungsstärkste Sequenzierplattform NovaSeq™ X Plus
CeGaT, ein global agierender Anbieter von Sequenzierdienstleistungen für Forschung, klinische Studien und humangenetisc…
First Provider in Germany: CeGaT Offers Sequencing Services Based on PacBio's SMRT Technology
CeGaT, a global provider of sequencing services for research, clinical trials, and human genetic diagnostics, is the fir…
